Shenzhen Amperex Biotechnology Co., Ltd. (referred to as Amperex Biotech) is a biotechnology enterprise that integrates basic research in life sciences, gene therapy, and commercial services for cell therapy.

Amperex Biotech insists on providing customers in the fields of life science research, live animal transfection, large-scale biological production, gene and cell therapy with nucleic acid transfection reagents that can be metabolized in cells; inviCELL ™ Platelet lyse animal serum free products are designed to support a wide range of cell expansion and production, including culturing mesenchymal stem cells and various immune cell lines, providing serum-free cell culture scale production services for pharmaceutical or biotechnology companies; Provide fully humanized and biodegradable 3D matrix gel products based on plant biology platform gene sequences through cell culture; Provide type I collagen products with endotoxin ≤ 1.0 EU/mL, non-toxic to cells, and high purity. Amperex Biotech focuses on providing high-quality products and technical services for the field of biomedicine, striving to develop into a biotechnology enterprise specializing in gene therapy and cell therapy.

Company Objective: Committed to becoming a trusted collaborator in promoting the progress of life sciences.